3187 results for «7919»

Filter By

3187 results

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

19 May 2021 – From EuroPCR 2021

Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti  and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

Right ventricule and tricuspid regurgitation: a linked faith

21 May 2025 – From EuroPCR 2025

Investigate the interconnected pathophysiology of right ventricular function and tricuspid regurgitation. This session reviews predictors of outcomes post-transcatheter tricuspid valve repair, the impact of disproportionate regurgitation, and changes in ventricular contraction patterns.

Right ventricule and tricuspid regurgitation: a linked faith

The aortic regurgitation problem: an imaging and practical perspective

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...

The aortic regurgitation problem: an imaging and practical perspective

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

21 May 2025 – From EuroPCR 2025

Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

Tricuspid hotline: new devices

22 May 2025 – From EuroPCR 2025

Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.

Tricuspid hotline: new devices

Assessment and management of patients with multivalvular disease involving the tricuspid valve

22 May 2025 – From EuroPCR 2025

Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.

Assessment and management of patients with multivalvular disease involving the tricuspid valve

Aortic valve disease: guidelines and beyond

22 Nov 2021 – From PCR London Valves 2021

Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...

Aortic valve disease: guidelines and beyond

Innovations in transcatheter tricuspid valve intervention - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Watch two very innovative tricuspid cases you've never seen before:

  • Part 1: TR replacement
    An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Innovations in transcatheter tricuspid valve intervention

EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease

17 May 2023 – From EuroPCR 2023

The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral...

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....

Prof. Tian-Hai Koh

Chairperson

Tian Hai Koh
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli
AsiaPCR/SingLIVE 2017:

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul
AsiaPCR/SingLIVE 2017:

Predictors outcome after tricuspid TEER: is there a perfect tool

22 May 2025 – From EuroPCR 2025

Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...

Predictors outcome after tricuspid TEER: is there a perfect tool

TAVI and coronary artery disease

22 May 2025 – From EuroPCR 2025

Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...

TAVI and coronary artery disease

When things threaten to go wrong: navigating procedural complications

22 May 2025 – From EuroPCR 2025

Develop critical skills for managing procedural complications in interventional cardiology. This session focuses on the identification and real-time management of common adverse events such as coronary dissection, perforation, tamponade, and embolism. Learn how to utilize echocardiographic imaging to assist in complication recognition and support your team...

When things threaten to go wrong: navigating procedural complications

Calcified coronaries: novel devices and techniques

22 May 2025 – From EuroPCR 2025

Gain expert insights into managing calcified coronary lesions with novel devices and techniques. Topics include the safety and efficacy of rotational atherectomy, the distal rail-tracking technique, impact of burr speed and duration, innovative scoring balloon designs, and the RODIN-CUT sequential cutting balloon angioplasty method for moderate-to-severe...

Calcified coronaries: novel devices and techniques

When mitral disease is not the only problem on mitral TEER patients

22 May 2025 – From EuroPCR 2025

Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...

When mitral disease is not the only problem on mitral TEER patients

CTO beyond the conventional: when new strategies come to the rescue

22 May 2025 – From EuroPCR 2025

Delve into advanced strategies for chronic total occlusion (CTO) beyond conventional methods. This session covers step-by-step re-entry techniques with electrified guidewires, approaches to CTO in small vessels, and indications and methods for occlusion of saphenous vein grafts, illustrated by detailed case discussions and key learnings.

Difficult decision-making in left main revascularisation

22 May 2025 – From EuroPCR 2025

Address difficult clinical decisions in left main coronary artery revascularization through this session featuring complex cases. Topics include prioritization in combined left main, aortic valve disease, and low ejection fraction, management of myocardial infarction with severe mitral regurgitation and cardiogenic shock, and unique cases such as...

Difficult decision-making in left main revascularisation

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics
Didn’t find what you were looking for?